Prenatal depression and adverse birth outcomes: an updated systematic review

EE Accortt, ACD Cheadle… - Maternal and child health …, 2015 - Springer
Complications related to preterm birth (PTB) and low birth weight (LBW) are leading causes
of infant morbidity and mortality. Prenatal depression is a hypothesized psychosocial risk …

Psychopharmacological treatment of obsessive-compulsive disorder (OCD)

A Del Casale, S Sorice, A Padovano… - Current …, 2019 - ingentaconnect.com
Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …

Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than …

SY Gao, QJ Wu, C Sun, TN Zhang, ZQ Shen, CX Liu… - BMC medicine, 2018 - Springer
Background In 2005, the FDA cautioned that exposure to paroxetine, a selective serotonin
reuptake inhibitor (SSRI), during the first trimester of pregnancy may increase the risk of …

[HTML][HTML] A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight

H Huang, S Coleman, JA Bridge, K Yonkers… - General hospital …, 2014 - Elsevier
Objectives To examine the relationship between antidepressant use in pregnancy and low
birth weight (LBW) and preterm birth (PTB). Data Sources and Study Selection We searched …

Antidepressant use in pregnancy: a critical review focused on risks and controversies

N Byatt, KM Deligiannidis… - Acta Psychiatrica …, 2013 - Wiley Online Library
Objective Conflicting data have led to controversy regarding antidepressant use during
pregnancy. The objectives of this study are to i) review the risks of untreated depression and …

Benefits and risks of antidepressant drugs during pregnancy: a systematic review of meta-analyses

P Desaunay, LG Eude, M Dreyfus, C Alexandre… - Pediatric Drugs, 2023 - Springer
Background The prescription of antidepressant drugs during pregnancy has been steadily
increasing for several decades. Meta-analyses (MAs), which increase the statistical power …

Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis

KF Huybrechts, RS Sanghani, J Avorn, AC Urato - PLoS One, 2014 - journals.plos.org
Introduction Preterm birth is a major contributor to neonatal morbidity and mortality and its
rate has been increasing over the past two decades. Antidepressant medication use during …

Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review

H El Marroun, T White, FC Verhulst… - European child & …, 2014 - Springer
Antidepressant and anxiolytic medications are widely prescribed and used by pregnant
women for acute and maintenance therapy. These drugs are able to pass the placental …

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population‐based cohort study

L Ban, JE Gibson, J West, L Fiaschi… - … Journal of Obstetrics …, 2014 - Wiley Online Library
Objective To estimate risks of major congenital anomaly (MCA) among children of mothers
prescribed antidepressants during early pregnancy or diagnosed with depression but …

Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality

O Stephansson, H Kieler, B Haglund, M Artama… - Jama, 2013 - jamanetwork.com
Importance Maternal psychiatric disease is associated with adverse pregnancy outcomes.
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy has been …